92 related articles for article (PubMed ID: 10628410)
1. Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen.
Paus E; Nustad K; Børmer OP
Tumour Biol; 1999; 20 Suppl 1():52-69. PubMed ID: 10628410
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of 53 antibodies against prostate-specific antigen.
Bellanger L; Andrès C; Seguin P
Tumour Biol; 1999; 20 Suppl 1():18-23. PubMed ID: 10628404
[TBL] [Abstract][Full Text] [Related]
3. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antibodies to prostate-specific antigen.
Nilsson O; Andersson I; Peter A; Karlsson B
Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen.
Leinonen J; Zhang WM; Paus E; Stenman UH
Tumour Biol; 1999; 20 Suppl 1():28-34. PubMed ID: 10628406
[TBL] [Abstract][Full Text] [Related]
6. Immunological grouping of 53 antibodies against prostate-specific antigen.
Slota J; Lauren L; Rapp J; Dowell B
Tumour Biol; 1999; 20 Suppl 1():70-4. PubMed ID: 10628411
[TBL] [Abstract][Full Text] [Related]
7. Relative affinity and specificity of monoclonal antibodies against prostate-specific antigen.
Jette DC; Kreutz FT; Suresh MR
Tumour Biol; 1999; 20 Suppl 1():24-7. PubMed ID: 10628405
[TBL] [Abstract][Full Text] [Related]
8. Analysis of monoclonal antibodies to prostate-specific antigen: reactivity with native and recombinant prostate-specific antigen.
Zhou Z; Barnett TR; Very DL; Ng PC; Pellegrino CM; Davis G; Belenky A; Allard WJ; Yeung KK
Tumour Biol; 1999; 20 Suppl 1():86-93. PubMed ID: 10628414
[TBL] [Abstract][Full Text] [Related]
9. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen.
Stenman UH; Paus E; Allard WJ; Andersson I; Andrès C; Barnett TR; Becker C; Belenky A; Bellanger L; Pellegrino CM; Børmer OP; Davis G; Dowell B; Grauer LS; Jette DC; Karlsson B; Kreutz FT; van der Kwast TM; Lauren L; Leinimaa M; Leinonen J; Lilja H; Linton HJ; Nap M; Hilgers J
Tumour Biol; 1999; 20 Suppl 1():1-12. PubMed ID: 10628402
[TBL] [Abstract][Full Text] [Related]
10. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
Nustad K; Bast RC; Brien TJ; Nilsson O; Seguin P; Suresh MR; Saga T; Nozawa S; Børmer OP; de Bruijn HW; Nap M; Vitali A; Gadnell M; Clark J; Shigemasa K; Karlsson B; Kreutz FT; Jette D; Sakahara H; Endo K; Paus E; Warren D; Hammarström S; Kenemans P; Hilgers J
Tumour Biol; 1996; 17(4):196-219. PubMed ID: 8685601
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
Corey E; Wegner SK; Corey MJ; Vessella RL
Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
[TBL] [Abstract][Full Text] [Related]
12. Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.
Zhou Z; Armstrong EG; Belenky A; Freeman JV; Yeung KK
J Clin Lab Anal; 1998; 12(4):242-9. PubMed ID: 9671177
[TBL] [Abstract][Full Text] [Related]
13. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
[TBL] [Abstract][Full Text] [Related]
14. Characterization and measurement of prostate-specific antigen using monoclonal antibodies.
Bélanger A; Rong PM; Liu S; Lavoie L; Labrie F
Clin Invest Med; 1993 Dec; 16(6):409-14. PubMed ID: 7516829
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
Corey E; Wegner SK; Stray JE; Corey MJ; Arfman EW; Lange PH; Vessella RL
Int J Cancer; 1997 Jun; 71(6):1019-28. PubMed ID: 9185706
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2.
Leinonen J; Leinimaa M; Zhang WM; Piironen T; Pettersson K; Lilja H; Dowell B; Stenman UH
Tumour Biol; 1999; 20 Suppl 1():35-7. PubMed ID: 10628407
[TBL] [Abstract][Full Text] [Related]
17. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
Nilsson O; Peter A; Andersson I; Nilsson K; Grundström B; Karlsson B
Br J Cancer; 1997; 75(6):789-97. PubMed ID: 9062397
[TBL] [Abstract][Full Text] [Related]
18. Western blotting analysis of antibodies to prostate-specific antigen: cross-reactivity with human kallikrein-2.
Wang TJ; Linton HJ; Rittenhouse HG; Wolfert RL
Tumour Biol; 1999; 20 Suppl 1():75-8. PubMed ID: 10628412
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
[TBL] [Abstract][Full Text] [Related]
20. Epitope analysis of a prostate-specific antigen (PSA) C-terminal-specific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays.
Nagasaki H; Watanabe M; Komatsu N; Kaneko T; Dubé JY; Kajita T; Saitoh Y; Ohta Y
Clin Chem; 1999 Apr; 45(4):486-96. PubMed ID: 10102908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
